The government plans to roll out the vaccination process in the next three months
Mayank Aggarwal@journomayank 12.14.2020 Source: Independent Featured Photo Source: Unsplash, Ashim D-Silva
The Peruvian government has suspended its trial of a major Chinese coronavirus vaccine candidate after a participant suffered a serious medical episode, even as the country claims it will begin rolling out jabs in the next three months.
The Peruvian minister of health Pilar Mazzetti said that the decision of the National Institute of Health (INS) to temporarily stop Sinopharm’s trial in the country was to evaluate the reason behind the adverse incident, which saw a participant experience neurological symptoms.
German Malaga, chief researcher at the local Cayetano Heredia University, which is involved in the study, said the volunteer had experienced decreased strength in his legs among other symptoms.
The authorities are trying to ascertain if the adverse incident is due to the vaccine or to other reasons. The vaccine was due to complete the first stage of the trials in the next few days.
The Sinopharm vaccine is not the only option available to Peru, and the government says it is in advanced stages of negotiations to acquire more than 26 million units of vaccine from Russia, China and the UK.
Many within the medical community including pharmaceutical manufacturers have question the speed and manner in which COVID 19 vaccines were being obtained. What are your thoughts on this? Which vaccine producer do you feel has created the best vaccine? Why?
If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today. All Rights Reserved – Shidonna Raven (c) 2025 – Garden & Cook.
Comments